Navigation Links
New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
Date:5/20/2008

s are working and self-management of dosing, as well as seven other related categories(1). The assessment of overall satisfaction was based on all the eleven ATSM items.

About the Study Design (Abstract A13)

Patient satisfaction was assessed in an open-label study involving 832 patients ages 18 years and older with moderate to severe asthma who were previously treated with ICS(1). After a 10-14 day run-in on previous ICS therapy, patients were randomized 2:1 to receive twice daily treatment with two inhalations of budesonide/formoterol combination therapy pressurized metered-dose inhaler (pMDI) fixed dose at 160/4.5 micrograms (mcg) (N=698) or twice daily treatment with one inhalation of fluticasone/salmeterol combination therapy dry powder inhaler (DPI) at 250/50 mcg (N=350)(1). After one month, patients on budesonide/formoterol combination therapy pMDI fixed dose were randomized 1:1 to continue budesonide/formoterol combination therapy pMDI fixed dose (N=333) or budesonide/formoterol combination therapy adjustable dose (N=330) at either once daily treatment with two inhalations of 160/4.5 mcg, twice daily treatment with two inhalations of 160/4.5 mcg, or twice daily treatment with four inhalations of 160/4.5 mcg for six months. The patients originally treated with fluticasone/salmeterol combination therapy remained on that medication (N=335)(1).

About SYMBICORT

SYMBICORT is a combination therapy indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older(2). Administered twice daily, SYMBICORT is a combination of two proven asthma medications -- budesonide, an inhaled corticosteroid (ICS), and formoterol, a rapid and long- acting beta2-agonist (LABA)(2). SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of asthma(2).

Important Safety Information

Long acting beta2-adrenergic agonists may increase the risk of asthma- related death. Therefore,
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
4. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
5. Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
6. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
7. Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
8. CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards
9. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
10. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
11. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire-USNewswire/ -- Nearly 600 medical research ... today convened to explore novel development appro...ugural Partnering for Cures meeting. ,, Fas...en Institute, convened Partnering for Cures to f...rn a scientific discovery into an accessible thera...
(Date:12/2/2009)...erlands, December 2 Pepscan Holdin...focusing on protein mimicking,technology for the g...hat it,has appointed Wim E.M. Mol, Ph.D. as new Ch...responsible for all of Pepscans corporate function...on of the company. He brings to,Pepscan more than ...
(Date:12/2/2009)...Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical..., a leading pharmaceutical company,specializing in...branded,generic and proprietary pharmaceuticals in... been included in China,s National Drug Reimbursem...istry of Human Resources and Social,Security on No...
(Date:12/1/2009)... Solomon announced that he has joined Carolina Eye...bsite at www.DrKerrySolomon.com , which was devel...a proven LASIK, lens implant, and cataract surgery... his substantial contributions to improving vision...SIK Surgeons, which screens LASIK surgeons based u...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...l , a Georgia-based maker of neural stem cell kits... can raise sufficient amounts of angel capital, a ...out of the University of Georgia in Athens in 20...e of Wisconsin and from Wisconsin Investment Part...ut it will need more backing from angel investors ...
... the well-attended BICSI Conference . While I was...data centers to get a first-hand view of its servi...ng some online research, and I figured I would hav...write another article because data centers have ...ers have become very important in the last couple ...
... expenses offset strong quarterly revenue as Soni...dia communications technology, reported a net loss...t quarter of fiscal year 2007. , ,The quarterly n...r 5 cents per share net loss in the same quarter o...sonally slow period, even though it reported reven...
Other Biology Technology:Wisconsin tries to woo another stem cell company 2Wisconsin tries to woo another stem cell company 3Data centers: Blowing smoke and raising red flags 2Data centers: Blowing smoke and raising red flags 3Data centers: Blowing smoke and raising red flags 4Data centers: Blowing smoke and raising red flags 5Data centers: Blowing smoke and raising red flags 6
(Date:12/3/2009)... comes to investment in energy efficient technolog...s Research Council (EPSRC) Chief Executive Dave De...engineering research has already brought us fuel c...more investment is needed to develop the capabilit...arbon emission targets by 2020 and limit the impac...
(Date:12/2/2009)...ed to secondhand cigarette smoke have an increased... if they never smoked. , Results of this study ...& Prevention , a journal of the American Associati...co focus in the December issue. , This year alo...with lung cancer; more than 159,000 will die from ...
(Date:12/2/2009)...ing and alcohol consumption before head and neck c...ture risk of death, according to published studies...t among those who continued these habits after can...seled to quit smoking; despite this, many still sm...ven after their cancer diagnosis, increasing their...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2The EU must allocate fewer emission allowances and stop making free allocations 10134 1The EU must allocate fewer emission allowances and stop making free allocations 10134 2The EU must allocate fewer emission allowances and stop making free allocations 10134 3More Women Having Other Breast Removed 58408 1More Women Having Other Breast Removed 58408 2More Women Having Other Breast Removed 58408 3Scientists Discover How Chemo Can Make Women Infertile 58404 1Scientists Discover How Chemo Can Make Women Infertile 58404 2Scientists Discover How Chemo Can Make Women Infertile 58404 3
...ecent findings published in the journal of Clinica...ant symptom reduction of chronic venous insufficie...nogenol® (pic-noj-en-all), an antioxidant plant ex...ee. Over 35 years of research on Pycnogenol® demo... flow and strengthen venous walls. Published resu...
...early half of the people responding to an online s... of their life rather than be fat, according to a ...ty at Yale. , The 4,000 respondents in varying num...er walk away from their marriage, give up the poss...e alcoholic rather than be obese. Five percent and...
...esearch by Warwick Medical School at the Universit...ssociated with an almost a two-fold increased risk...arly results of a study by Professor Francesco Cap...cal School were presented to the International AC2...rsity of Warwick. , The research reviewed curren...
Other Biology News:Study shows pine bark naturally decreases severe chronic venous insufficiency 2Study shows pine bark naturally decreases severe chronic venous insufficiency 3Some people would give life or limb not to be fat 2Sleep deprivation doubles risks of obesity in both children and adults 2
Rabbit Anti-Mi-2 Polyclonal Antibody, Unconjugated from Upstate
...cope V is a fully integrated system for fluoresce...ing that deliver excellent quality microarray imag...canner that is based on patented confocal laser im...and spatial resolution. The DNAscope V images two ...
Rabbit Anti-Retinoic Acid Receptor beta 2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human Synaptogyrin 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: